Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain

Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain

**Background:** Anti-thrombotic prophylaxis is routinely used in patients undergoing elective total hip or knee replacement (THR or TKR) to reduce the risk of venous thromboembolism (VTE). In Spain, pharmacological prophylaxis is performed with low-molecular-weight heparin, enoxaparin being the most...

Full description

Bibliographic Details
Main Authors: Xavier Granero Xiberta, Antonio Murcia, José Ricardo Troncoso Durán, Claudio Gómez Zubeldia, Aleix Llorac Moix, Ruth Graefenhain De Codes, Maria Giovana Ferrario, Luis Lizán
Format: Article
Language:English
Published: Columbia Data Analytics, LLC
Series:Journal of Health Economics and Outcomes Research
Online Access:http://jheor.scholasticahq.com/article/9824-budget-impact-of-rivaroxaban-for-the-prevention-of-thromboembolic-events-after-hip-or-knee-replacement-in-spain.pdf

Internet

http://jheor.scholasticahq.com/article/9824-budget-impact-of-rivaroxaban-for-the-prevention-of-thromboembolic-events-after-hip-or-knee-replacement-in-spain.pdf

Similar Items